Display search results for ** instead (38 products)

Showing 1-10 of 38

18 Mar 2016  |  North America

Vital Signs - Drug Development Focus on Genetically Modified Swine

Modified Swine Hold out Promise of Improving Pre-Clinical Efficacy, Lowering Multi-billion Dollar Drug and Device Development Costs

The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...

USD 450.00

USD 337.50 save 25 %

18 Mar 2016  |  North America

Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery

Additional Clinical Trials Critical to Building on Early Promise

As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemic stroke victims have permanent symptoms and only ...

USD 450.00

USD 337.50 save 25 %

21 Sep 2015  |  North America

Vital Signs - Review of AHRA 2015: Key Conference Takeaways and Gadolinium Based MR Contrast Agents Safety Issues

Overview of Top Themes from the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA)

A record-high attendance of 1,000 radiology directors and managers convened to the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA 2015) held this year in Las Vegas. Radiology is going through interesting times indeed. Under the coordinated care paradigm that is gradually emerging in the U.S., and with all the changes th...

USD 450.00

USD 337.50 save 25 %

02 Jun 2015  |  North America

CMS Changes in Chronic Care Management

Is it Really a Bridge to Value-based Care?

The U.S. Healthcare Insurance market is undergoing a period of change. There is building momentum among Governmental officials to initiate these changes by implementing new payment models starting with the Medicare system. The goal is to transition from a procedure-based physician fee model to an outcomes-based care coordination team approach that...

USD 500.00

USD 375.00 save 25 %

Imaging informatics did grab its fair share of attention and footprint on the HIMSS 2015 showfloor.This is attributable to the fields ongoing focus shift away from departmental solutions, to enterprise solutions: vendor neutral archives, enterprise viewers, image sharing and enterprise workflow orchestrators. These products areas are not, however, ...

USD 450.00

USD 337.50 save 25 %

Overview and discussion of a key theme from the ECR 2015 Annual Meeting, on major steps taken towards globalizing evidence-based imaging guidelines.

USD 500.00

USD 375.00 save 25 %

Overview and discussion of the top themes from the RSNA 2014 Annual Meeting, with a focus on the vendor Exhibit Floor.

USD 500.00

USD 375.00 save 25 %

As the Wearables sector continues to explode in interest in the healthcare space in terms of potential hard benefit to consumers, providers, and vendors across the value chain of connected healthcare, areas are expanding in launches besides that of activity tracking. The following Vital Signs presents analyst discussion regarding brain wearables in...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on December 5, 2014, discusses LabCorps acquisition of Covance, MedImmunes acquisition of Definiens, the Google X cancer and heart attack detector, and VWRs acquisition of two fluid handling components companies.

USD 500.00

USD 375.00 save 25 %

This issue of Vital Signs, released on November 6, 2014, discusses Immucors collaboration with Sirona Genomics, Becton Dickinsons acquisition of GenCell Biosystems, and an update on the Ebola virus.

USD 500.00

USD 375.00 save 25 %

Showing 1-10 of 38